Call Us Now
+91-9891296838

VELCADE ® (bortezomib) for Injection

VELCADE is a proteasome inhibitor indicated for:
• treatment of patients with multiple myeloma
• treatment of patients with mantle cell lymphoma

DOSAGE FORMS AND STRENGTHS
• Single-use vial contains 3.5 mg of bortezomib as lyophilized powder

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDM), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

9 + 14 =

Bortezomib is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans. Proteasomes are cellular complexes that break down proteins. In some cancers, the proteins that normally kill cancer cells are broken down too quickly. Bortezomib interrupts this process and lets those proteins kill the cancer cells. It is approved in the U.S. and Europe for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.

Reviews

There are no reviews yet.

Be the first to review “VELCADE ® (bortezomib) for Injection”

Your email address will not be published. Required fields are marked *